Today’s guest: Ardy Arianpour | Co-Founder and CEO of Seqster
Greg and Ardy talk about the possibilities created by Seqster – the “Mint.com of health data.”
Ardy Arianpour is CEO & Co-Founder of Seqster, a data-driven healthcare SaaS platform that seamlessly integrates into any payer, provider, or clinical research enterprise. Seqster provides person-centric interoperability to retrieve and harmonize electronic health records (EHR), genetic, and continuous monitoring data from distinct sources. Ardy is a visionary health tech executive and serial entrepreneur in the biotech industry. Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and SVP of Ambry Genetics that sold to Konica for $1B in 2017. As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country. Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management.
Important links:
Seqster Web Site: https://seqster.com/
Ardy’s LinkedIn: https://www.linkedin.com/in/ardyarianpour/
Eric Topol’s Post about Seqster: https://twitter.com/EricTopol/status/1031970997707010048
Article: Seqster’s Perfect Timing, Powerful Platform Might Change Health: http://www.bio-itworld.com/2018/09/18/seqsters-perfect-timing-powerful-platform-might-change-health.aspx
